Latest filing published 08 Oct 2025 for Verona Pharma plc. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Christina Ackermann is a declared insider at 4 companies (senior executive); the most frequent names are Bausch Health Companies Inc., Verona Pharma plc and Bausch & Lomb Corp. The record holds 14 filings, for trades running from 2 June 2021 to 7 October 2025.
On the open market, the record shows 1 purchase worth €181k and 1 sale worth €21k. On balance, insiders were net buyers of €161k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 6 share grants and 4 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
On 8 October 2025 came the latest disclosure, a transaction in Verona Pharma plc. The clock since the last published purchase (7 November 2024) now reads 710 days. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations